An analysis of the risk of B-lymphocyte malignancies in industrial cohorts

John A Bukowski1, Wendy W Huebner, A Robert Schnatter

  • 1ExxonMobil Biomedical Sciences, Inc., Annandale, New Jersey, USA. john.a.bukowski@exxonmobil.com

Related Concept Videos